FDA, Novavax and influenza vaccine
The right time is now to get your flu vaccine, says the FDA
Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug Administration says.
FDA places hold on Novavax’s COVID and influenza vaccine
A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its development while more information is gathered.
FDA puts Novavax's phase 3 plan for pair of vaccine programs on hold over nerve disease case
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu programs on hold in response to a case of nerve disease from a former parti | The phase 2 trial wrapped up in July 2023,
Novavax reports FDA placed clinical hold on IND for COVID-flu combo vaccine
Novavax announced that the U.S. Food and Drug Administration has placed a clinical hold on Novavax’s Investigational New Drug, or IND, application for its COVID-19-Influenza Combination, or CIC, and stand-alone influenza vaccine candidates.
FDA Puts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Tumbles
Wednesday said the U.S. Food and Drug Administration (FDA) has placed a clinical hold on its COVID-19-Influenza
Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines
Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and standalone flu inoculation, sending shares down sharply.
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
Shares of Novavax NVAX lost nearly 20% on Wednesday after the company announced that the FDA has placed a clinical hold on its experimental COVID-19-Influenza Combination (“CIC”) and stand-alone influenza vaccine candidates.
FDA halts Novavax's vaccine trials after safety scare
The U.S. Food and Drug Administration (FDA) has suspended Novavax's experimental combined COVID-19 and flu vaccine clinical trials. This decision followed reports of a participant's symptoms of nervous system damage,
Novavax shares sink as US FDA puts trial of combo COVID-flu vaccine on hold
Shares in Novavax (NASDAQ:NVAX) slumped in premarket US trading on Wednesday after the US Food and Drug Administration placed a trial of its experimental COVID-19 and influenza vaccine combination on hold.
Novavax stock plunges as FDA puts clinical hold on COVID-flu combo vaccine
Shares of Novavax (NASDAQ:NVAX) fell roughly 30% Wednesday morning after the U.S. FDA put a clinical hold on the new drug application of its COVID-19 and influenza combination vaccine and standalone influenza vaccine candidates,
The Chronicle12h
Duke Human Vaccine Institute to develop avian flu vaccine protecting against variants, provide long-lasting immunity
The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...
2minutemedicine.com2d
AstraZeneca’s FluMist first and only self-administered flu vaccine
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
FDA Updates Sanofi's FLUBLOK Vaccine Label With New Safety Data For Pregnant Individuals
Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...
Portfolio1d
Free influenza vaccine to be available in Hungary by end-October
The Respiratory Surveillance Service has begun operating in Hungary as a first step in preparing for the flu season.